A-Z of Treatment Side Effects & Treatment-Related Complication Terms

​​

Alopecia (Hair Loss)

Alopecia, commonly known as hair loss, is one of the most recognizable side effects of cancer treatment. Certain chemotherapy drugs used to treat Wilms tumor can temporarily affect hair follicles, leading to partial or complete hair loss on the scalp and sometimes other areas of the body. Hair loss is usually temporary, and hair commonly begins to regrow after treatment has been completed.

 

Appetite Changes

Appetite changes are common during cancer treatment and may involve decreased appetite, increased appetite, food aversions, or altered eating habits. Chemotherapy, medications, emotional stress, nausea, and changes in taste can all contribute to appetite-related challenges. Maintaining adequate nutrition is an important part of supporting recovery and treatment tolerance.

 

Bladder Toxicity

Bladder toxicity refers to damage or irritation affecting the bladder as a result of certain chemotherapy drugs, particularly cyclophosphamide and ifosfamide. Symptoms may include pain during urination, blood in the urine, increased urinary frequency, or bladder inflammation. Preventive measures and close monitoring help reduce the risk of significant complications.

 

Bone Marrow Suppression

Bone marrow suppression occurs when cancer treatment reduces the bone marrow's ability to produce healthy blood cells. This can result in anemia, neutropenia, and thrombocytopenia. Bone marrow suppression is one of the most common side effects of chemotherapy and requires careful monitoring through regular blood testing.

 

Cardiotoxicity

Cardiotoxicity refers to damage affecting the heart that may occur during or after cancer treatment. Certain chemotherapy drugs, particularly doxorubicin, are associated with an increased risk of cardiac complications. Long-term follow-up often includes echocardiograms and cardiac assessments to monitor heart health and identify problems as early as possible.

 

Chemotherapy-Induced Fatigue

Chemotherapy-induced fatigue is a persistent feeling of tiredness that is not fully relieved by rest. Fatigue can affect physical activity, concentration, school participation, emotional well-being, and overall quality of life. It is one of the most common side effects experienced during childhood cancer treatment and may continue for some time after therapy has ended.

 

Constipation

Constipation can occur as a side effect of chemotherapy, medications, reduced physical activity, dehydration, or dietary changes. Children receiving cancer treatment may experience difficulty passing stools or reduced bowel frequency. Supportive care strategies often include hydration, nutritional adjustments, physical activity, and medications when necessary.

 

Delayed Growth

Delayed growth may occur when cancer treatment affects normal childhood development. Certain chemotherapy drugs, radiation therapy, nutritional challenges, and endocrine complications can contribute to slower growth rates. Long-term monitoring of height, weight, and developmental milestones is an important aspect of survivorship care.

 

Dehydration

Dehydration occurs when the body loses more fluids than it takes in. Vomiting, diarrhea, poor oral intake, fever, and treatment side effects can increase the risk of dehydration during cancer treatment. Maintaining adequate hydration is essential for supporting kidney function, treatment tolerance, and overall health.

 

Diarrhea

Diarrhea is a common side effect of some chemotherapy drugs and medications used during cancer treatment. Frequent loose stools can lead to dehydration, electrolyte imbalances, nutritional challenges, and discomfort. Prompt management is important to minimize complications and support recovery.

 

Endocrine Disorders

Endocrine disorders involve abnormalities affecting hormone production and regulation. Some childhood cancer survivors may experience endocrine complications involving growth, puberty, fertility, thyroid function, or metabolism. Long-term follow-up with endocrinology specialists may be recommended when treatment-related endocrine issues are identified.

 

Fatigue

Fatigue is one of the most common side effects associated with childhood cancer treatment. It can result from chemotherapy, radiation therapy, anemia, emotional stress, poor nutrition, or sleep disturbances. Fatigue may affect a child's ability to participate in normal daily activities and often requires a combination of medical management, nutritional support, and rest.

 

Fertility Problems

Fertility problems may occur when cancer treatments affect reproductive organs or hormone production. Although many children treated for Wilms tumor maintain normal fertility, certain chemotherapy drugs, radiation treatments, and stem cell transplant procedures may increase the risk of future reproductive complications. Fertility preservation discussions are increasingly recognized as an important aspect of care.

 

Gastrointestinal Toxicity

Gastrointestinal toxicity refers to treatment-related effects involving the digestive system. Symptoms may include nausea, vomiting, diarrhea, abdominal pain, constipation, reduced appetite, and nutritional difficulties. Effective supportive care can help manage gastrointestinal complications and improve quality of life during treatment.

 

Hearing Loss (Ototoxicity)

Hearing loss, sometimes referred to as ototoxicity, may occur following treatment with certain chemotherapy drugs, particularly platinum-based agents such as cisplatin. Hearing changes can affect communication, education, and social development. Survivorship programs often include hearing assessments for children who received treatments associated with ototoxicity.

 

Heart Disease

Heart disease can develop as a long-term complication of certain cancer treatments. Although uncommon, some survivors may experience changes in heart function many years after therapy has ended. Regular cardiac monitoring helps identify and manage treatment-related cardiovascular risks throughout survivorship.

 

Infection Risk

Infection risk increases when chemotherapy suppresses the immune system and reduces the number of infection-fighting white blood cells. Children receiving treatment may be more vulnerable to bacterial, viral, and fungal infections. Preventive measures, early intervention, and close monitoring are essential components of pediatric oncology care.

 

Kidney Toxicity (Nephrotoxicity)

Kidney toxicity, also known as nephrotoxicity, refers to damage affecting kidney function. Certain chemotherapy drugs, radiation treatments, and surgical procedures can impact renal health. Because the kidneys are directly involved in Wilms tumor treatment and survivorship, ongoing monitoring of kidney function remains an important part of long-term care.

 

Late Effects

Late effects are health problems that appear months, years, or decades after cancer treatment has been completed. Wilms tumor survivors may experience late effects involving the kidneys, heart, lungs, fertility, endocrine system, hearing, or psychological well-being. Lifelong follow-up helps identify and manage these complications.

 

Lung Toxicity

Lung toxicity refers to damage affecting the lungs that may result from certain chemotherapy drugs, radiation therapy, infections, or metastatic disease. Symptoms can include coughing, reduced exercise tolerance, shortness of breath, or breathing difficulties. Pulmonary monitoring may be recommended for children at increased risk.

 

Mucositis

Mucositis is inflammation and irritation of the lining of the mouth, throat, or digestive tract. Chemotherapy can damage rapidly dividing cells in these tissues, resulting in painful ulcers, difficulty eating, and increased infection risk. Effective mouth care and supportive treatments can help reduce symptoms and improve comfort.

 

Nausea

Nausea is one of the most common side effects of cancer treatment and may result from chemotherapy, medications, radiation therapy, or emotional stress. Modern anti-nausea medications have significantly improved symptom control, helping children maintain nutrition, hydration, and quality of life throughout treatment.

 

Neutropenia

Neutropenia occurs when chemotherapy reduces the number of neutrophils, a type of white blood cell responsible for fighting infection. Severe neutropenia can significantly increase infection risk and may require treatment delays, growth factor support, hospitalization, or preventive measures to protect patient safety.

 

Neurocognitive Effects

Neurocognitive effects refer to changes affecting memory, concentration, learning, processing speed, and other cognitive functions. Although less common in Wilms tumor than in some other childhood cancers, neurocognitive challenges may occur due to treatment, prolonged illness, or emotional stress. Educational support may be beneficial when difficulties arise.

 

Peripheral Neuropathy

Peripheral neuropathy is nerve damage that may occur as a side effect of chemotherapy drugs such as vincristine. Symptoms can include numbness, tingling, weakness, pain, balance problems, or difficulty performing fine motor tasks. Early recognition and management are important to minimize long-term effects.

 

Psychological Distress

Psychological distress may affect both children and family members during and after cancer treatment. Anxiety, depression, fear of relapse, social isolation, and emotional stress are common experiences. Psychological support services play an important role in promoting emotional well-being and resilience.

 

Secondary Cancer

Secondary cancer is a new and unrelated cancer that develops as a late effect of previous cancer treatment. Although relatively uncommon, certain chemotherapy drugs and radiation therapy exposures may slightly increase long-term cancer risk. Survivorship programs include monitoring strategies designed to support early detection.

 

Taste Changes

Taste changes occur when cancer treatment alters the way food tastes or smells. Children may notice that foods taste metallic, bland, bitter, or different than usual. Taste changes can contribute to appetite loss and nutritional challenges but often improve after treatment is completed.

 

Thrombocytopenia

Thrombocytopenia is a reduction in the number of platelets, the blood cells responsible for clotting. Low platelet counts can increase the risk of bruising, bleeding, and delayed healing. Regular blood testing helps monitor platelet levels throughout treatment and guide supportive care decisions.

 

Treatment Toxicity

Treatment toxicity is a general term describing harmful effects caused by cancer therapies. Toxicities may affect virtually any organ system and can occur during treatment or years later. Understanding treatment toxicity is essential for balancing treatment effectiveness with long-term health and quality of life.

 

Vomiting

Vomiting may occur as a result of chemotherapy, medications, infections, radiation therapy, or gastrointestinal complications. Persistent vomiting can lead to dehydration, weight loss, nutritional deficiencies, and reduced treatment tolerance. Early management and supportive care are important to minimize complications.

 

Weight Loss

Weight loss may occur during cancer treatment because of reduced appetite, nausea, vomiting, taste changes, increased energy demands, or disease-related factors. Monitoring weight and nutritional status helps healthcare teams identify concerns early and provide appropriate dietary support.

 

White Blood Cell Suppression

White blood cell suppression refers to reduced production of infection-fighting white blood cells by the bone marrow. This is a common consequence of chemotherapy and contributes significantly to infection risk. Regular blood testing helps monitor immune recovery and guide treatment decisions.